Clinical Trial Update: Open-label Treatment in Cushing's Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 open-label trial for Cushing's syndrome and Cushing disease sponsored by Cortendo AB has completed, with results posted in June 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Disease
• Cushing Syndrome

Snippet

Sponsor: Cortendo AB | Conditions: Cushing Syndrome, Cushing Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-06-19